Investment in 4d Pharma plc

Target Company Name:
Country:
Advisory:
Sector:
Partner:

4d Pharma plc
United Kingdom
Advisor
Healthcare & Pharmaceuticals
Zeus

4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on significant new therapeutic areas, announces that it has today conditionally placed 8,475,610 new ordinary shares

UK Based - Pharmaceutical Company Microbiome field and the discovery and development of bacteria £34.75 million raise

Advisor :
Zeus

Relevant transactions

Transactions

Project Amygdala

Private Equity

Sale of mental health services provider for high-acuity individuals in the UK

Advisor to the seller :
Cooper Parry Corporate Finance

Private Investors

Sale of a minority stake of Genbio, a hemoderivatives producer, to Private Investors

Advisor to the seller :
RIóN

icotec, the world leader in the field of spinal tumor implants, has closed its USD 30m growth financing round led by MVM

Advisor

Alpha Source Group, a portfolio company of Baird Capital, acquired by Probo Medical.

Advisor to the seller :
Brown Gibbons Lang & Company